On May 21, 2025, Plus Therapeutics, Inc. received a notice from Nasdaq indicating it is not compliant due to a delay in filing its Quarterly Report for March 31, 2025, and has until July 21, 2025, to address this compliance issue. The notice does not impact the company's current listing status on Nasdaq.